Ramin Tehranchi (Former)

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/b01ce382-5ff0-4ea4-8f7c-2f87118d79c4?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark Phase 1/2a clinical trial of BI-1206, an anti-CD32b (FcγRIIB) antibody, in combination with pembrolizumab in subjects with advanced solid tumors previously treated with anti-PD-1/PD-L1.
Carneiro, Ana ^LU ; Yachnin, Jeffrey ; Aljumaily, Raid ; Abel, Edvard ; Falchook, Gerald Steven ; Ji, Yan ; Borggren, Marie ^LU ; Mårtensson, Linda ^LU ; Gertsson, Susanne and Karlsson, Ingrid ^LU , et al. (2024) In Journal of Clinical Oncology 42. p.2593-2593
- Contribution to journal › Scientific review
2006
Mark Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.
Tehranchi, Ramin ^LU (2006) In Medical Oncology 23(1). p.37-49
- Contribution to journal › Scientific review
2005
Mark Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
Tehranchi, Ramin ^LU ; Invernizzi, R ; Grandien, A ; Zhivotovsky, B ; Fadeel, B ; Forsblom, AM ; Travaglino, E ; Samuelsson, J ; Hast, R and Nilsson, L , et al. (2005) In Blood 106(1). p.247-253
- Contribution to journal › Article